Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth

View ORCID ProfileYi Li, Meng Liang, Xianhong Yin, Xiaoyu Liu, Meng Hao, Zixin Hu, Yi Wang, Li Jin
doi: https://doi.org/10.1101/2020.03.01.20029819
Yi Li
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
2Institute for Six-sector Economy, Fudan University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yi Li
Meng Liang
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianhong Yin
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoyu Liu
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meng Hao
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zixin Hu
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Wang
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lijin@fudan.edu.cn wangyi_fudan@fudan.edu.cn
Li Jin
1Ministry of Education Key Laboratory of Contemporary Anthropology, Human Phenome Institute, School of Life Sciences, Fudan University, China
2Institute for Six-sector Economy, Fudan University, Shanghai, China
3Institute of Data Sciences, Fudan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lijin@fudan.edu.cn wangyi_fudan@fudan.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Background In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China. Now the situation is almost controlled in China but is worse outside China. We aimed to build a mathematical model to capture the global trend of epidemics outside China.

Methods In this retrospective, outside-China diagnosis number reported from Jan 21 to Feb 28, 2020 was downloaded from WHO website. We develop a simple regression model on these numbers: Embedded Image where Nt is the total diagnosed patient till the ith day, t=1 at Feb 1.

Findings Based on this model, we estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China. The global trend is approximately exponential, with the rate of 10 folds every 19 days.

Evidence before this study In December 2019, pneumonia infected with a novel coronavirus burst in Wuhan, China. Now the situation is almost controlled in China but is worse outside China. Now there are 4,691 patients across 51 countries and territories outside China. We searched PubMed and the China National Knowledge Infrastructure database for articles published up to Feb 28, 2020, using the keywords “COVID”, “novel coronavirus”, “2019-nCoV” or “2019 novel coronavirus”. No published work about the global trend of epidemics outside China could be identified.

Added value of this study We built a simple “log-plus” linear model to capture the global trend of epidemics outside China. We estimate that there have been about 34 unobserved founder patients at the beginning of spread outside China. The global trend is approximately exponential, with the rate of 10 folds every 19 days.

Implications of all the available evidence With the limited number of data points and the complexity of the real situation, a straightforward model is expected to work better. Our model suggests that the COVID-19 disease follows an approximate exponential growth model stably at the very beginning. We predict that the number of confirmed patients outside China will increase ten folds in every 19 days without strong intervention by applying our model. Powerful actions on public health should be taken to combat this epidemic all over the world.

Introduction

In early December of 2019, pneumonia cases of unknown cause emerged in Wuhan, the capital of Hubei province, China.1 A novel coronavirus (now named as COVID-19) was verified and identified as the seventh member of enveloped RNA coronavirus (subgenus sarbecovirus, Orthocoronavirinae subfamily) through high-throughput sequencing.2-4 Human-to-human transmission in hospital and family settings had been accumulating 5-7 and has occurred among close contacts since the middle of December 2019 based on evidence from early transmission dynamics.8 According to WHO statistics, the accumulating number of diagnosed patients in China was 78,961 in Feb 28, 2020.9

COVID-19 raised intension not only within China but internationally. Since the first case of pneumonia caused by COVID-19 was reported from Wuhan, COVID-19 patients had rapidly been diagnosed in other cities of China and the neighboring countries including Thailand, South Korea, Japan, and even to a few Western countries.10-12 On January13 2020, the Ministry of Public Health of Thailand reported the first imported case of lab-confirmed novel coronavirus (2019-nCoV). 13 As of Feb28 2020, cases had been reported in 52 countries and territories. The number of confirmed COVID-19 cases had reached 4,691 outside China, 9 and the number is still increasing. South Korea, the worst affected country outside China, has reported another jump. The 571 new cases brought South Korea’s total confirmed cases to 2,337. A surge in cases of COVID-19 in Italy, Japan and Iran also heightened fears that the world is on the brink of a pandemic.14 In Feb 28, WHO increased the assessment of the risk of spread and risk of impact of COVID-19 to very high at the global level.

Recently, many researchers devoted to more details about the analysis of the spread of epidemic.14,15 Some paralleled results have shown that the reproductive number R0 estimated of COVID-19 is bigger than that of SARS based on different models. 16-18 With the limited number of data points and the complexity of the real situation, a straightforward model is expected to work better (see Discussion). In this study, we propose a “log-plus” model for the situation prediction which only requires daily number of total diagnosis outside China. This model assumes that there were some unobserved founder patients at the beginning of spread outside China and exponential growth later. Despite the simplicity of our model, it fits the data well (R2=0.991). The prediction is expected to provide practical significance on social application and evidence for enhancing public health interventions to avoid severe outbreaks.

Methods

Data

Daily diagnosis number of countries outside China is download from WHO situation reports (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports). The data in this analysis starts from Jan 21 and currently it ends at Feb 28.

Model

We first explored the data by plotting log transformed daily number. We observed a good linear trend recently, but a relatively poor fit at the beginning of spread. We therefore consider that there are some unobserved founder patients at the beginning. Based on exploratory data analysis and mathematical intuition we proposed the following model: Embedded Image where Nt is the number of diagnosed patients outside China according to WHO at the tth day, t=1 at Feb 1; u is the number of unobserved founder patients at the beginning of spread outside China; a and b are simple linear regression parameters. We enumerated u from 0 to 100 with step size 1. For each u, we calculated Pearson’s correlation R2 between t and log10 (Nt +u). We selected the û that maximize R2 and estimate corresponding â and Embedded Image using a simple linear regression between t and log10 (Nt +û).

Availability of source code

The source code of model estimation is at: https://github.com/wangyi-fudan/COVID-19_Global_Model

Results

Data Table

The WHO daily count of diagnosis number outside China and its “log-plus” transform as well as model fit were shown in table 1.

View this table:
  • View inline
  • View popup
Table 1: WHO Daily Diagnosis Number Outside China

Parameter Estimation

û, â and Embedded Image were estimated as 34, 0·0515 and 2·075 respectively according to Feb 28 data (figure 1)

Figure 1:
  • Download figure
  • Open in new tab
Figure 1: Estimation of u Parameter by Enumeration

Global Trend Model

We plot log10 (Nt + 34) against time to visualize the model fitting (figure 2). The model R2 is 0·991 indicating an excellent model fit.

Figure 2:
  • Download figure
  • Open in new tab
Figure 2: The Exponential Growth of COVID-19 Infection Outside China

Future Number Prediction

Currently the number of diagnoses at Febuary 28 is 4,691. We predict that the number of diagnoses outside China will expand exponentially with the rate of 10 folds every 19 days without strong intervention.

Conclusion

Based on this model, we estimated that there have been about 34 unobserved founder patients at the beginning of spread outside China. Our model suggests that the COVID-19 disease follows an approximate exponential growth model stably at the very beginning. The situation is dangerous as we expect 10 folds increases of patients every 19 days without strong intervention. We call on world-wide strong actions on public health referring to experiences learnt from China and Singapore.

Discussion

In this report, we only analyzed the total number of diagnoses outside China. The country scale data is available but is not as complete as total number. Here, we limited this analysis to capture the global trend.

This model is a minimal extension of the ‘default’ exponential growth model with the estimation of 34 unobserved founder patients outside China. An almost perfect model fitting (R2=0·991) indicates that the spread of disease does follow our model.

A simple and straightforward linear model inherits with some advantages: (1) it works on small sample size due to limited observation or somewhat unperfect data. (2) it is relatively robust in complex situations. The virus spreading pattern is complex and yet varies across the world. A simple model simplified the situation and provides coarse-grained trend estimation. (3) A linear model has nice extrapolation ability comparing to complex models (e.g. Neural network).

The existent of 34 unobserved founder patients is not surprising. They may have mild symptoms thus did not went to the hospitals. However, we did not preclude the possibility that they already existed before or parallel with Wuhan’s burst.

Data Availability

Daily diagnosis number of countries outside China is download from WHO situation reports (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports).

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

Contributors

YW conceived the idea and wrote the source code. YW, YL, ML and LJ contributed data analysis, generating tables and figures, and manuscript writing. YL, ML, XY, LX, MH, ZH, YW, LJ contributed the theoretical analysis and manuscript revision. All authors contributed to final revision of the manuscript.

Declaration of interests

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank the Fudan University High-End Computing Center for supporting computations involved in this study.

References

  1. 1.↵
    Huang C, Wang Y, Li X, et al. Clinical features of patients with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; doi: 10.1016/S0140-6736(20)30183-5
    OpenUrlCrossRefPubMed
  2. 2.↵
    Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications of virus origins and receptor binding. Lancet. 2020; doi: 10.1016/S0140-6736(20)30251-8
    OpenUrlCrossRefPubMed
  3. 3.
    https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020
  4. 4.↵
    Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; doi: 10.1056/NEJMoa2001017
    OpenUrlCrossRefPubMed
  5. 5.
    Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; doi: 10.1016/S0140-6736(20)30154-9
    OpenUrlCrossRefPubMed
  6. 6.
    Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020; doi: 10.1056/NEJMc2001272
    OpenUrlCrossRefPubMed
  7. 7.
    Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modeling study. Lancet. 2020;
  8. 8.↵
    Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 2020; published online. doi: 10.1056/NEJMoa2001316
    OpenUrlCrossRefPubMed
  9. 9.↵
    https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200226-sitrep-37-covid-19.pdf?sfvrsn=2146841e_2
  10. 10.↵
    Kim H. Outbreak of novel coronavirus (COVID-19): What is the role of radiologists? 2020.
  11. 11.
    Shao N, Pan H, Li X, et al. CoVID-19 in Japan: What could happen in the future? medRxiv, 2020.
  12. 12.↵
    Ryu S, Ali S T, Lim J, et al. The estimate of infected individuals of the 2019-Novel Coronavirus in South Korea by incoming international students from the countries of risk of 2019-Novel Coronavirus: a simulation study. medRxiv, 2020.
  13. 13.↵
    https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200227-sitrep-38-covid-19.pdf?sfvrsn=9f98940c_2
  14. 14.↵
    Shao N, Cheng J, Chen W. The reproductive number R0 of COVID-19 based on estimate of a statistical time delay dynamical system. medRxiv 2020; doi:10.1101/2020.02.17.20023747 (preprint).
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Zhao Q, Chen Y, Small D S. Analysis of the epidemic growth of the early 2019-nCoV outbreak using internationally confirmed cases. medRxiv, 2020.
  16. 16.↵
    Xiong H, Yan H. Simulating the infected population and spread trend of 2019-nCov under different policy by EIR model. Available at SSRN 3537083, 2020.
  17. 17.
    Mizumoto K, Kagaya K, Chowell G. Early epidemiological assessment of the transmission potential and virulence of 2019 Novel Coronavirus in Wuhan City: China, 2019-2020. medRxiv, 2020.
  18. 18.↵
    Zhao S. et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. International Journal of Infectious Diseases, 2020.
View Abstract
Back to top
PreviousNext
Posted March 05, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth
Yi Li, Meng Liang, Xianhong Yin, Xiaoyu Liu, Meng Hao, Zixin Hu, Yi Wang, Li Jin
medRxiv 2020.03.01.20029819; doi: https://doi.org/10.1101/2020.03.01.20029819
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
COVID-19 Epidemic Outside China: 34 Founders and Exponential Growth
Yi Li, Meng Liang, Xianhong Yin, Xiaoyu Liu, Meng Hao, Zixin Hu, Yi Wang, Li Jin
medRxiv 2020.03.01.20029819; doi: https://doi.org/10.1101/2020.03.01.20029819

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (141)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4797)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (670)
  • Geriatric Medicine (69)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (84)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5275)
  • Intensive Care and Critical Care Medicine (323)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (676)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (437)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (764)
  • Public and Global Health (1795)
  • Radiology and Imaging (320)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (254)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)